These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1849205)

  • 1. [Clinical features of anti-HCV antibody positive hepatocellular carcinoma].
    Hayashi S; Tanaka S; Wakashima M; Saeki S; Tanaka T; Shibayama T; Otake H; Hattori N
    Nihon Rinsho; 1991 Feb; 49(2):432-8. PubMed ID: 1849205
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
    Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
    Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and virological analysis of the non-A, non-B hepatitis negative for HCV antibody (anti-C-100)].
    Kamimura T; Miyajima T; Okoshi S; Kojima H; Asakura H; Shimotono K
    Nihon Rinsho; 1991 Feb; 49(2):409-11. PubMed ID: 1849201
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma.
    Watanabe Y; Harada S; Saito I; Miyamura T
    Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of HCV-ELISA using synthetic peptide].
    Takahashi T; Hayashi N; Shikata T
    Nihon Rinsho; 1991 Feb; 49(2):347-50. PubMed ID: 1849192
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Katayama K; Fusamoto H; Kamada T
    Dig Dis Sci; 1992 Jan; 37(1):65-72. PubMed ID: 1309450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
    Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
    Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
    Yu ZY
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of anti-hepatitis C virus in the sera of different populations of Beijing].
    Zhonghua Yi Xue Za Zhi; 1992 Jan; 72(1):18-20, 62-3. PubMed ID: 1374286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV transmission after receiving anti-c100-negative blood units.
    Inaba S; Fukuda M; Okochi K; Irita Y; Tokunaga K; Kiyokawa H; Maeda Y
    Lancet; 1991 Jun; 337(8753):1354. PubMed ID: 1709435
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characterization of hepatitis C related markers and control of hepatitis C infection].
    Yoshizawa H
    Nihon Koshu Eisei Zasshi; 1992 Aug; 39(8):441-4. PubMed ID: 1327295
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interpretation of Ortho HCV Ab ELISA test results by chiron HCV recombinant immunoblot assay].
    Yahagi N; Kitsugi K
    Rinsho Byori; 1991 Jan; 39(1):26-33. PubMed ID: 1848912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma.
    Kiyosawa K; Tanaka E; Sodeyama T; Furuta K; Usuda S; Yousuf M; Furuta S
    Jpn J Cancer Res; 1990 Nov; 81(11):1089-91. PubMed ID: 2176199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus.
    Ryder SD; Koskinas J; Rizzi PM; McFarlane IG; Portmann BC; Naoumov NV; Williams R
    Hepatology; 1995 Sep; 22(3):718-22. PubMed ID: 7657274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-HCV in heavy drinker].
    Yasuyama T
    Nihon Rinsho; 1991 Feb; 49(2):439-45. PubMed ID: 1849206
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between markers for viral hepatitis and clinical features of Japanese patients with hepatocellular carcinoma: possible role of alcohol in promoting carcinogenesis.
    Matsuda Y; Amuro Y; Higashino K; Hada T; Yamamoto T; Fujikura M; Yamaguchi K; Shimomura S; Iijima H; Nakano T
    Hepatogastroenterology; 1995 Apr; 42(2):151-4. PubMed ID: 7545640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance and the problems of HCV antibody].
    Yano M
    Nihon Rinsho; 1991 Feb; 49(2):402-8. PubMed ID: 1849200
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevalence of HCV antibodies from mass survey in Shimane Prefecture].
    Ikeda S; Uchida M; Fukumoto S; Shimada Y
    Nihon Rinsho; 1991 Feb; 49(2):378-82. PubMed ID: 1849196
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of antibody to hepatitis C virus (anti-HCV) in chronic liver diseases (CLD) in southern Italy.
    Amitrano L; Ascione A; Canestrini C; D'Agostino S; Iaccarino L; Vacca C; Gigliotti T
    Ital J Gastroenterol; 1990 Feb; 22(1):16-8. PubMed ID: 1966702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.